GSK · GSK plc · Webcasts, Transcripts & Audio
$48.58
-0.66 (-1.34%)
At close · Nov 18
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$97.38B
Shares
2.00B
Volume · Nov 18
2.2M
Avg daily vol (3M)
4.03M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
GSK plc Webcasts
Earnings calls, investor updates, investor days and conferences for GSK plc (GSK), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q4
2027-02-03
GSK plc (GSK) Q4 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-11-17
GSK plc (GSK) November 17, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-10
GSK plc (GSK) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-28
GSK plc (GSK) Q3 2026 Earnings Call Transcript
Positive tone
R&D acceleration
Exdensur launch
Nucala competition
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-23
GSK plc (GSK) September 23, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-09
GSK plc (GSK) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-09
GSK plc (GSK) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-28
GSK plc (GSK) Q2 2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
GSK plc (GSK) Q1 2026 Earnings Call Transcript
Confident tone
HIV long-acting portfolio
Specialty Medicines growth
Pipeline and R&D priorities
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-04
GSK plc (GSK) Q4 2025 Earnings Call Transcript
Confident tone
HIV long-acting portfolio transition
Exdensur (depmokimab) launch in respiratory
Blenrep launch and ramp
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–10 of 10 webcasts
Key facts
CIK
1131399
CUSIP
37733W204
13F (30d)
922 filings
845 filers
Visit website
Investor relations